Too much of a good thing can be bad: the pros and cons of pharmaceutical patents

Carrie Conaway

Regional Review, 2003, issue Q 1, pages 10-18

Abstract: Pharmaceutical firms-and society-depend on patent protection to foster the development of new drugs. But patents also raise prices and reduce access by delaying generic competition.

Keywords: Drugs - Patents; Pharmaceutical industry (search for similar items in EconPapers)
Date: 2003

Downloads: (external link)
http://www.bos.frb.org/economic/nerr/rr2003/q1/toomuch.htm (text/html)
http://www.bos.frb.org/economic/nerr/rr2003/q1/toomuch.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:fip:fedbrr:y:2003:i:q1:p:10-18

Ordering information: This journal article can be ordered from

Access Statistics for this article

More articles in Regional Review from Federal Reserve Bank of Boston
Contact information at EDIRC.
Series data maintained by Diane Rosenberger ().